High-Throughput, Automated Protein A Purification Platform with Multiattribute LC-MS Analysis for Advanced Cell Culture Process Monitoring

被引:38
作者
Dong, Jia [1 ]
Migliore, Nicole [2 ]
Mehrman, Steven J. [3 ]
Cunningham, John [4 ]
Lewis, Michael J. [1 ]
Hu, Ping [1 ]
机构
[1] Janssen Res & Dev, Pharmaceut Dev & Mfg Sci, Large Mol Analyt Dev, Malvern, PA 19355 USA
[2] Janssen Res & Dev, Pharmaceut Dev & Mfg Sci, Act Pharmaceut Ingredient Large Mol, Malvern, PA 19355 USA
[3] Janssen Res & Dev, Pharmaceut Dev & Mfg Sci, Strateg Operat, Spring House, PA 19477 USA
[4] Janssen Res & Dev, Pharmaceut Dev & Mfg Sci, Mat Sci, Malvern, PA 19355 USA
关键词
ANALYTICAL TECHNOLOGY PAT; MONOCLONAL-ANTIBODY; QUALITY; GLYCOSYLATION; GLYCATION; DESIGN; IMPACT; TOOLS;
D O I
10.1021/acs.analchem.6b01956
中图分类号
O65 [分析化学];
学科分类号
070302 [分析化学];
摘要
The levels of many product related variants observed during the production of monoclonal antibodies are dependent on control of the manufacturing process, especially the cell culture process. However, it is difficult to characterize samples pulled from the bioreactor due to the low levels of product during the early stages of the process and the high levels of interfering reagents. Furthermore, analytical results are often not available for several days, which slows the process development cycle and prevents "real time" adjustments to the manufacturing process. To reduce the delay and enhance our ability to achieve quality targets, we have developed a low-volume, high-throughput, and high-content analytical platform for at-line product quality analysis. This workflow includes an automated, 96-well plate protein A purification step to isolate antibody product from the cell culture fermentation broth, followed by rapid, multiattribute LC-MS analysis. We have demonstrated quantitative correlations between particular process parameters with the levels of glycosylated and glycated species in a series of small scale experiments, but the platform could be used to monitor other attributes and applied across the biopharmaceutical industry.
引用
收藏
页码:8673 / 8679
页数:7
相关论文
共 34 条
[1]
Acton Q. A., 2013, ANTIBODIES ADV RES A
[2]
A new tool for monoclonal antibody analysis Application of IdeS proteolysis in IgG domain-specific characterization [J].
An, Yan ;
Zhang, Ying ;
Mueller, Hans-Martin ;
Shameem, Mohammed ;
Chen, Xiaoyu .
MABS, 2014, 6 (04) :879-893
[3]
[Anonymous], 2011, PAT APPL BIOPHARMACE
[4]
Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies [J].
Beck, Alain ;
Debaene, Francois ;
Diemer, Helene ;
Wagner-Rousset, Elsa ;
Colas, Olivier ;
Van Dorsselaer, Alain ;
Cianferani, Sarah .
JOURNAL OF MASS SPECTROMETRY, 2015, 50 (02) :285-297
[5]
Characterization of Therapeutic Antibodies and Related Products [J].
Beck, Alain ;
Wagner-Rousset, Elsa ;
Ayoub, Daniel ;
Van Dorsselaer, Alain ;
Sanglier-Cianferani, Sarah .
ANALYTICAL CHEMISTRY, 2013, 85 (02) :715-736
[6]
CMC Biotech Working Group Study Guide, 2009, A-Mab: A Case Study in Bioprocess Development
[7]
An automated robotic platform for rapid profiling oligosaccharide analysis of monoclonal antibodies directly from cell culture [J].
Doherty, Margaret ;
Bones, Jonathan ;
McLoughlin, Niaobh ;
Telford, Jayne E. ;
Harmon, Bryan ;
DeFelippis, Michael R. ;
Rudd, Pauline M. .
ANALYTICAL BIOCHEMISTRY, 2013, 442 (01) :10-18
[8]
Monitoring protein aggregation kinetics with simultaneous multiple sample light scattering [J].
Drenski, Michael F. ;
Brader, Mark L. ;
Alston, Roy W. ;
Reed, Wayne F. .
ANALYTICAL BIOCHEMISTRY, 2013, 437 (02) :185-197
[9]
Quality attributes of recombinant therapeutic proteins: An assessment of impact on safety and efficacy as part of a quality by design development approach [J].
Eon-Duval, Alex ;
Broly, Herve ;
Gleixner, Ralf .
BIOTECHNOLOGY PROGRESS, 2012, 28 (03) :608-622
[10]
Process analytical technology (PAT) for biopharmaceuticals [J].
Glassey, Jarka ;
Gernaey, Krist V. ;
Clemens, Christoph ;
Schulz, Torsten W. ;
Oliveira, Rui ;
Striedner, Gerald ;
Mandenius, Carl-Fredrik .
BIOTECHNOLOGY JOURNAL, 2011, 6 (04) :369-377